Skip to Main Content

Paper Details

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
Cell
368
2020
COVID-19, SARS, SARS-CoV-2, immune cell classes, immune cell phenotypes, immune cells, patients
Author NameAffiliation
Yapeng SuInstitute for Systems Biology
Guangrong QinInstitute for Systems Biology
Alissa C RothchildCenter for Global Infectious Disease Research, Seattle Children's Research Institute
John C EarlsInstitute for Systems Biology
Nathan D PriceInstitute for Systems Biology
Nathan D PriceInstitute for Systems Biology
Naeha SubramanianInstitute for Systems Biology, University of Washington
Andrew T MagisInstitute for Systems Biology
Jennifer J HadlockInstitute for Systems Biology
Leroy HoodInstitute for Systems Biology
Leroy HoodInstitute for Systems Biology
Alan AderemCenter for Global Infectious Disease Research, Seattle Children's Research Institute
Raphael GottardoFred Hutchinson Cancer Research Center, University of Washington
Raphael GottardoFred Hutchinson Cancer Research Center, University of Washington
Mark M DavisInstitute for Immunity, Stanford University School of Medicine, USA The Howard Hughes Medical Institute
James R HeathInstitute for Systems Biology, University of Washington
  • 1 - 16

Datasets